The Trump Administration is planning to announce action on prescription drug pricing as early as next week, but it seems unlikely that major changes impacting manufacturers are imminent.
HHS will release a request for information (RFI) from stakeholders on various drug pricing ideas, according to White House Deputy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?